NEW HAVEN, Conn., June 14, 2012 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that Michael D. Kishbauch, President and Chief Executive Officer of Achillion, will present a corporate overview at the 2012 Wells Fargo Securities Healthcare Conference. The presentation will take place at the InterContinental Hotel in Boston, MA on Tuesday, June 19, 2012 at 11:15 a.m. EDT.